Communiqués Swedish Orphan Biovitrum AB

Actions

SOBI

SE0000872095

Marché Fermé - Nasdaq Stockholm Autres places de cotation 17:29:30 31/05/2024			Varia. 5j.	Varia. 1 janv.
282,4 ^SEK	+1,66 %		+0,79 %	+5,77 %

28/05	BerGenBio ASA conclut un accord d'essai clinique avec le Mays Cancer Center de l'Université du Texas Health Science Center de San Antonio et Swedish Orphan Biovitrum AB	CI
14/05	Swedish Orphan Biovitrum AB (publ) élit Zlatko Rihter comme nouveau membre du conseil d'administration	CI

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Sobi to present new myelofibrosis data at the ASCO 2024 Annual Meeting	24/05	GL
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome	24/05	GL
Bulletin from Sobi's Annual General Meeting (AGM)	14/05	AQ
Sobi has completed SEK 3 billion senior bond issue	08/05	AQ
Aspaveli® (pegcetacoplan) approved in Europe for use among treatment naïve adult patients with PNH	08/05	AQ
Sobi® receives positive CHMP opinion recommending approval of efanesoctocog alfa for once-weekly treatment of haemophilia A	26/04	AQ
Sobi establishes MTN programme with a framework amount of SEK 10 billion, publishes a base prospectus	26/04	AQ
Swedish Orphan Biovitrum : 25 april - Q1 2024 rapport	25/04	PU
Swedish Orphan Biovitrum : 25 April - Q1 2024 report	25/04	PU
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio	25/04	AQ
Invitation: Sobi's Q1 2024 report	15/04	PU
Notice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)	04/04	AQ
Swedish Orphan Biovitrum : Sobi publishes Annual and sustainability report for 2023	02/04	PU
Sobi publishes Annual and sustainability report for 2023	02/04	AQ
Swedish Orphan Biovitrum : Sobi announces positive results from phase 3 study of Doptelet® for treatment of children and adolescents with ITP	25/03	PU
Sobi publishes Q4 2023 report: Strong revenue performance and growth into 2024	08/02	AQ
Sobi to present new data at EAHAD 2024	31/01	AQ
Sobi's Chairman of the Board resigns due to health reasons	05/01	AQ
Change in number of shares and votes in Swedish Orphan Biovitrum AB (publ)	30/11	AQ
Sobi to present new data at ASH 2023 Annual Meeting	20/11	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Swedish Orphan Biovitrum AB

Actions

SOBI

SE0000872095

Communiqués

Filtres